Sunshine Biopharma Inc. (SBFMW) Operating cash flow 2016–2025
Sunshine Biopharma Inc. (SBFMW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.3MFY2025 · since FY2016: -$314,182 → -$5.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.3M | +57.4% |
| FY2024 | -$12.5M | -42.7% |
| FY2023 | -$8.8M | -67.2% |
| FY2022 | -$5.2M | -186.9% |
| FY2021 | -$1.8M | -178.3% |
| FY2020 | -$657,299 | -32.6% |
| FY2019 | -$495,798 | +3.3% |
| FY2018 | -$512,806 | +5.7% |
| FY2017 | -$543,520 | -73.0% |
| FY2016 | -$314,182 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFMW financial trends
SBFMW RevenueSBFMW Net incomeSBFMW Net marginSBFMW Gross profitSBFMW Gross marginSBFMW Operating incomeSBFMW Operating marginSBFMW Free cash flowSBFMW Capital expendituresSBFMW Return on equitySBFMW Stock buybacksSBFMW Dividends paidSBFMW Total assetsSBFMW Total liabilitiesSBFMW Shareholders’ equitySBFMW overview →